From: Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C)
Drug concept name
N (%)
remdesivir
20,762 (88.5%)
remdesivir 100 MG Injection
2471 (10.5%)
remdesivir Injection
187 (0.80%)
20 ML remdesivir 5 MG/ML Injection
30 (0.13%)